ECO 2026: GLP-1 Therapy Linked to Fewer Asthma Exacerbations Tags GLP-1 agonists Read more about ECO 2026: GLP-1 Therapy Linked to Fewer Asthma Exacerbations
HF 2026: Transient Serum Lipase Rise Observed During AHF in AVANTI Analysis Tags Heart Failure Read more about HF 2026: Transient Serum Lipase Rise Observed During AHF in AVANTI Analysis
HF 2026: APAC Delphi Consensus Provides Regional Guidance for ATTR-CM Management Tags Dilated Cardiomyopathy Hypertrophic Cardiomyopathy Restrictive Cardiomyopathy Takotsubo Cardiomyopathy Read more about HF 2026: APAC Delphi Consensus Provides Regional Guidance for ATTR-CM Management
HF 2026: Lower Serum Adropin Levels Associated with Increased Heart Failure Progression Risk Tags Heart Failure Read more about HF 2026: Lower Serum Adropin Levels Associated with Increased Heart Failure Progression Risk
HF 2026: Hypochloremia and Venous Congestion Might Alter AKI Risk in Acute Heart Failure Tags Heart Failure Read more about HF 2026: Hypochloremia and Venous Congestion Might Alter AKI Risk in Acute Heart Failure
HF 2026: 2023 ESC ACS Guideline Adoption Associated with Fewer In-Hospital Complications Tags Acute Coronary Syndrome Read more about HF 2026: 2023 ESC ACS Guideline Adoption Associated with Fewer In-Hospital Complications
ECO 2026: New Consensus Guidance Issued for Incretin-Based Obesity Treatment Tags GLP-1 agonists Read more about ECO 2026: New Consensus Guidance Issued for Incretin-Based Obesity Treatment
ECO 2026: GLP-1-Based Obesity Therapy Reduced Fat More Than Muscle Mass Tags GLP-1 agonists Read more about ECO 2026: GLP-1-Based Obesity Therapy Reduced Fat More Than Muscle Mass
AID Increased Time in Range in Diabetes With Advanced CKD Tags Diabetic Nephropathy hBA1c Insulin Pumps Others Delivery devices Continuous glucose monitoring (CGM) Read more about AID Increased Time in Range in Diabetes With Advanced CKD
FPG/1-Hour Glucose Staging Outperformed HbA1c Schemas Tags FBS hBA1c Read more about FPG/1-Hour Glucose Staging Outperformed HbA1c Schemas